MedTrace Logo

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

NCT01202747 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-12-06

Study results available
· View outcomes & findings →

Summary

The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.

Conditions

  • Chalazion
  • Dry Eye Syndromes

Interventions

DEVICE

LipiFlow System

In-office treatment for meibomian gland dysfunction

Sponsors & Collaborators

  • TearScience, Inc.

    lead INDUSTRY

Principal Investigators

  • Christy Stevens, OD · TearScience

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202747 on ClinicalTrials.gov